File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Multifunctional Injectable Bioadhesive with Toll-like Receptor 4 and Myeloid Differentiation Factor 2 Antagonistic Anti-inflammatory Potential for Periodontal Regeneration

TitleMultifunctional Injectable Bioadhesive with Toll-like Receptor 4 and Myeloid Differentiation Factor 2 Antagonistic Anti-inflammatory Potential for Periodontal Regeneration
Authors
Keywordsantagonist
anti-inflammation
bioadhesive
injectable hydrogels
multifunctional hydrogel
periodontal regeneration
xylitol
Issue Date14-Feb-2025
PublisherAmerican Chemical Society
Citation
ACS Nano, 2025, v. 19, n. 7, p. 7098-7116 How to Cite?
Abstract

Effectively addressing inflammation in periodontitis is challenging as conventional injectable hydrogels typically require the addition of drugs to provide sufficient anti-inflammatory effects. To overcome this limitation, we developed a multifunctional injectable hydrogel with inherent properties that antagonize the Toll-like receptor 4 and myeloid differentiation factor 2 complex (TLR4-MD2). This hydrogel allows for direct inhibition of inflammatory pathways without the need for additional drugs. We identified xylitol, caffeic acid, and citric acid as natural materials that effectively meet biological needs for anti-inflammatory and antibacterial effects as well as support bone regeneration. With this in mind, we developed a caffeic-acid-modified poly(xylitol succinate) (PXS)-based iCPC@MgO composite hydrogel and tested its potential application for periodontal regeneration. The iCPC@MgO hydrogel demonstrated rapid wet tissue adhesion and injectability, which are ascribed to incorporating catechol groups derived from caffeic acid. Intriguingly, the PXS polymer used for synthesizing the hydrogel was found to possess anti-inflammatory properties and act as an antagonist for the TLR4-MD2 complex. This hydrogel also exhibited outstanding antibacterial efficiency against Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans by stimulating antibiotic synthesis within bacteria and disrupting bacterial cell walls. In a periodontitis mouse model, the iCPC@MgO hydrogel demonstrated the therapeutic potential of reducing inflammatory factors, inhibiting dominant periodontitis-associated bacteria, and maintaining subgingival microbiota balance in addition to the regenerative effects. These properties, combined with their ecofriendly nature, firmly established the iCPC@MgO hydrogel as a highly promising option for use in periodontitis therapy as well as in tissue healing, repair, and regeneration in various other inflammatory conditions.


Persistent Identifierhttp://hdl.handle.net/10722/355313
ISSN
2023 Impact Factor: 15.8
2023 SCImago Journal Rankings: 4.593

 

DC FieldValueLanguage
dc.contributor.authorGao, Shuting-
dc.contributor.authorLi, Huihua-
dc.contributor.authorLi, Zekun-
dc.contributor.authorWang, Hong-
dc.contributor.authorLi, Xinyue-
dc.contributor.authorYang, Shengyan-
dc.contributor.authorHuang, Lin-
dc.contributor.authorZhang, Baoping-
dc.contributor.authorZhang, Kailiang-
dc.contributor.authorTsoi, James Kit Hon-
dc.contributor.authorHe, Jian-
dc.contributor.authorDissanayaka, Waruna Lakmal-
dc.date.accessioned2025-04-03T00:35:06Z-
dc.date.available2025-04-03T00:35:06Z-
dc.date.issued2025-02-14-
dc.identifier.citationACS Nano, 2025, v. 19, n. 7, p. 7098-7116-
dc.identifier.issn1936-0851-
dc.identifier.urihttp://hdl.handle.net/10722/355313-
dc.description.abstract<p>Effectively addressing inflammation in periodontitis is challenging as conventional injectable hydrogels typically require the addition of drugs to provide sufficient anti-inflammatory effects. To overcome this limitation, we developed a multifunctional injectable hydrogel with inherent properties that antagonize the Toll-like receptor 4 and myeloid differentiation factor 2 complex (TLR4-MD2). This hydrogel allows for direct inhibition of inflammatory pathways without the need for additional drugs. We identified xylitol, caffeic acid, and citric acid as natural materials that effectively meet biological needs for anti-inflammatory and antibacterial effects as well as support bone regeneration. With this in mind, we developed a caffeic-acid-modified poly(xylitol succinate) (PXS)-based iCPC@MgO composite hydrogel and tested its potential application for periodontal regeneration. The iCPC@MgO hydrogel demonstrated rapid wet tissue adhesion and injectability, which are ascribed to incorporating catechol groups derived from caffeic acid. Intriguingly, the PXS polymer used for synthesizing the hydrogel was found to possess anti-inflammatory properties and act as an antagonist for the TLR4-MD2 complex. This hydrogel also exhibited outstanding antibacterial efficiency against Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans by stimulating antibiotic synthesis within bacteria and disrupting bacterial cell walls. In a periodontitis mouse model, the iCPC@MgO hydrogel demonstrated the therapeutic potential of reducing inflammatory factors, inhibiting dominant periodontitis-associated bacteria, and maintaining subgingival microbiota balance in addition to the regenerative effects. These properties, combined with their ecofriendly nature, firmly established the iCPC@MgO hydrogel as a highly promising option for use in periodontitis therapy as well as in tissue healing, repair, and regeneration in various other inflammatory conditions.</p>-
dc.languageeng-
dc.publisherAmerican Chemical Society-
dc.relation.ispartofACS Nano-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectantagonist-
dc.subjectanti-inflammation-
dc.subjectbioadhesive-
dc.subjectinjectable hydrogels-
dc.subjectmultifunctional hydrogel-
dc.subjectperiodontal regeneration-
dc.subjectxylitol-
dc.titleMultifunctional Injectable Bioadhesive with Toll-like Receptor 4 and Myeloid Differentiation Factor 2 Antagonistic Anti-inflammatory Potential for Periodontal Regeneration-
dc.typeArticle-
dc.identifier.doi10.1021/acsnano.4c15922-
dc.identifier.scopuseid_2-s2.0-85218429549-
dc.identifier.volume19-
dc.identifier.issue7-
dc.identifier.spage7098-
dc.identifier.epage7116-
dc.identifier.eissn1936-086X-
dc.identifier.issnl1936-0851-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats